For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
VQQFTEREVDGVVIVAAVGAIDMLTAPQLQEAVAAAARRRPSGLVVDLTSVDFLGSAGMQVLMETRKGLD GDTRFAVVADGPATSRPLKITGITDYVDLYPSLDVALADLAG
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. gilvum PYR-GCK | Mflv_2021 | - | - | 100% (112) | anti-sigma-factor antagonist |
| M. gilvum PYR-GCK | Mflv_3284 | - | 3e-25 | 50.96% (104) | anti-sigma-factor antagonist |
| M. gilvum PYR-GCK | Mflv_4938 | - | 1e-14 | 39.05% (105) | anti-sigma-factor antagonist |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb3712c | - | 4e-10 | 37.50% (72) | hypothetical protein Mb3712c |
| M. tuberculosis H37Rv | Rv3687c | rsfB | 3e-16 | 35.19% (108) | anti-anti-sigma factor RSFB (anti-sigma factor antagonist) |
| M. leprae Br4923 | - | - | - | - | - |
| M. abscessus ATCC 19977 | - | - | - | - | - |
| M. marinum M | MMAR_0214 | - | 8e-22 | 48.54% (103) | hypothetical protein MMAR_0214 |
| M. avium 104 | MAV_5272 | - | 5e-25 | 50.47% (107) | anti-anti-sigma factor |
| M. smegmatis MC2 155 | MSMEG_6127 | - | 1e-27 | 55.24% (105) | anti-anti-sigma factor |
| M. thermoresistible (build 8) | TH_0498 | - | 3e-24 | 50.94% (106) | anti-anti-sigma factor |
| M. ulcerans Agy99 | MUL_3602 | - | 7e-09 | 37.04% (108) | anti sigma factor antagonist |
| M. vanbaalenii PYR-1 | Mvan_4702 | - | 1e-44 | 75.89% (112) | anti-sigma-factor antagonist |
CLUSTAL 2.0.9 multiple sequence alignment
Mb3712c|M.bovis_AF2122/97 ------------------------------------------------MA
Rv3687c|M.tuberculosis_H37Rv -------MSAPDSITVTVADHNGVAVLSIGGEIDLITAAALEEAIGEVVA
Mflv_2021|M.gilvum_PYR-GCK ------------MQQFTEREVDGVVIVAAVGAIDMLTAPQLQEAVAAAAR
Mvan_4702|M.vanbaalenii_PYR-1 ------------MQQFTEHQIDGVLVVAAVGAVDMLTAPQLQEAINAALD
MSMEG_6127|M.smegmatis_MC2_155 -----MTSQDPANCTVEERRVGDITVVAVTGTVDMLTAPKLEDAIGSAAK
TH_0498|M.thermoresistible__bu --------------VIDERWDADIAVVSATGVVDMLSAPQLDEAIRTALG
MMAR_0214|M.marinum_M MVEQSGDPTPPTAFGIEKSRVGEAVVVTVSGELDMLTAPRLAEMLRTSLI
MAV_5272|M.avium_104 MGEQPGDLADPTPFEVGKHQVDQAVVLTVSGEVDMLSSPMLAEAVQTALA
MUL_3602|M.ulcerans_Agy99 ----------MDLLAVEHEVRQDTVVVRAKGDVDSSTVEQLVVHLAAAMQ
Mb3712c|M.bovis_AF2122/97 DNPTA----LVIDLSAVEFLGSVGLKILAATSEK-IGQSVKFGVVARGSV
Rv3687c|M.tuberculosis_H37Rv DNPTA----LVIDLSAVEFLGSVGLKILAATSEK-IGQSVKFGVVARGSV
Mflv_2021|M.gilvum_PYR-GCK RRPSG----LVVDLTSVDFLGSAGMQVLMETRKG-LDGDTRFAVVADGPA
Mvan_4702|M.vanbaalenii_PYR-1 RQPTG----VVVDLTAVDFLGSAGMQVLMTTRRQ-LEGTVKFAVVADGPA
MSMEG_6127|M.smegmatis_MC2_155 SEPSA----VVVDLSAVDFLASAGMGVLVAAHGE-LAPAVRLVVVADGPA
TH_0498|M.thermoresistible__bu KKPRA----LVVDFTAVDFLASAGMGVLVAIHDE-VSPAVNLTIVADGPA
MMAR_0214|M.marinum_M EAPAT----LIVDLSKVDFLASAGMTVLVSAKAQ-AVAPTRFVVVADGPA
MAV_5272|M.avium_104 AKPAA----LIVDLSKVGFLASAGMTVLVTTQAE-LQPPTKFAVVADGSA
MUL_3602|M.ulcerans_Agy99 LAATHPARLVVIDLQPVTFFGSAGLNAVLECHEQGMAAGTSVRLVADHGQ
. :::*: * *:.*.*: : . . :**
Mb3712c|M.bovis_AF2122/97 TRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR-------
Rv3687c|M.tuberculosis_H37Rv TRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR-------
Mflv_2021|M.gilvum_PYR-GCK TSRPLKITGITDYVDLYPSLDVALADLAG------------
Mvan_4702|M.vanbaalenii_PYR-1 TSRPLKITGIADYVDLFSTLDVALRNLAG------------
MSMEG_6127|M.smegmatis_MC2_155 TSRPLKLVGIADVVDLFATLDEALSSLKT------------
TH_0498|M.thermoresistible__bu TSRPLKLLGIADLVPLHATLDEALAAVAT------------
MMAR_0214|M.marinum_M TSRPIRLMGIDAMLPLYDALDDALNDISDS-----------
MAV_5272|M.avium_104 TSRPIKLMGIDSVLSLYPSLNDALSALSGA-----------
MUL_3602|M.ulcerans_Agy99 LLAPIQVTELDRIFEIYPTLAGALRPGKPGEHDLEDVERPR
*::: : . :. :* **